$524 Thousand is the total value of North Growth Management Ltd.'s 47 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
JBL | Buy | JABIL | $38,561 | +10.9% | 288,000 | +5.5% | 7.36% | -0.7% |
CROX | Buy | CROCS | $12,403 | +92.7% | 86,000 | +24.6% | 2.37% | +72.6% |
LITE | Buy | LUMENTUM | $10,338 | -0.3% | 218,000 | +10.1% | 1.97% | -10.7% |
ATKR | Buy | ATKORE | $7,321 | +26.9% | 38,000 | +5.6% | 1.40% | +13.7% |
ODFL | Buy | OLD DOMINION FREIGHT LINE | $6,581 | +7.3% | 30,000 | +100.0% | 1.26% | -4.0% |
Buy | WARNER BROS DISCOVERY INC | $6,460 | -13.4% | 740,000 | +13.0% | 1.23% | -22.5% | |
WST | Buy | WEST PHARMACEUTICAL SERVICES | $6,191 | +42.6% | 16,000 | +33.3% | 1.18% | +27.6% |
LULU | Buy | LULULEMON ATHLETICA | $131 | -23.4% | 0 | +100.0% | 0.02% | -30.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-04-30
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLIED MATERIALS | 27 | Q2 2024 | 7.6% |
CIENA | 27 | Q2 2024 | 6.3% |
JABIL | 27 | Q2 2024 | 9.3% |
HP Inc | 27 | Q2 2024 | 3.8% |
APPLE | 27 | Q2 2024 | 6.4% |
ELEVANCE HEALTH | 27 | Q2 2024 | 3.7% |
FEDEX CORP | 27 | Q2 2024 | 3.1% |
JOHNSON CONTROLS INTERNATIONAL PLC | 27 | Q2 2024 | 2.7% |
ELECTRONIC ARTS INC | 27 | Q2 2024 | 2.8% |
MICROSOFT CORPORATION | 27 | Q2 2024 | 5.1% |
View North Growth Management Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-07-25 |
13F-HR | 2024-04-30 |
13F-HR | 2024-02-07 |
13F-HR | 2023-10-19 |
13F-HR | 2023-07-20 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-09 |
13F-HR | 2022-10-17 |
13F-HR | 2022-07-18 |
13F-HR | 2022-04-14 |
View North Growth Management Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.